Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
APS Biocontrol is a Scotland-based biotechnology company that specializes in developing natural, phage-based solutions for controlling bacterial pathogens in the agriculture and food industries. The company utilizes its proprietary Biotector platform to discover and formulate specific bacteriophage cocktails that target and eliminate harmful bacteria, such as Pectobacterium and Dickeya, which cause significant crop losses. By providing an environmentally friendly alternative to traditional chemical pesticides and antibiotics, APS Biocontrol aims to enhance food security and reduce waste across the global supply chain. Their products are designed to be highly targeted, ensuring that beneficial microbes remain unharmed while protecting the quality and safety of fresh produce.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on APS Biocontrol.